Connect with us
European Gaming Congress 2024

Fintech PR

Private Equity Market to Reach $1,098.74 billion, Globally, by 2032 at 9.7% CAGR: Allied Market Research

Published

on

private-equity-market-to-reach-$1,09874-billion,-globally,-by-2032-at-9.7%-cagr:-allied-market-research

One major growth factor for the private equity market is increased interest from institutional investors seeking higher returns in a low-interest-rate environment. Institutions like pension funds and endowments are allocating more capital to private equity due to its potential for superior returns compared to traditional investments like stocks and bonds, driving significant growth in the sector.

WILMINGTON, Del., Dec. 11, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Private Equity Market by Fund Type (Buyout, Venture Capital, Real Estate, Infrastructure, and Others), and Sector (Technology, Financial Services, Real Estate and Services, Healthcare, Energy and Power, Industrial, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032″. According to the report, the global private equity market size was valued at $445.4 billion in 2022 and is projected to reach $1,098.74 billion by 2032, growing at a CAGR of 9.7% from 2023 to 2032. 

Request Research Report Sample & TOC:
https://www.alliedmarketresearch.com/request-sample/7314 

(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution, Potential and COVID-19 Impact Analysis)

  • 104 – Tables
  • 54 – Charts
  • 351 – Pages

Private equity refers to a form of investment where funds are pooled from various sources, such as institutional investors, high-net-worth individuals, or pension funds, to acquire ownership stakes in private companies. Contrary to publicly traded companies, these investments are not listed on stock exchanges. Private equity firms deploy these funds to purchase a significant portion or the entirety of a company, aiming to enhance its value over time through active management strategies. They work closely with the management of the acquired company, implementing operational improvements, strategic changes, and growth initiatives to maximize its performance and ultimately generate returns for investors. Private equity spans various stages of businesses, from startups to established companies, and often involves restructuring expansion, or turnaround efforts to unlock the full potential of the company before exiting the investment through avenues such as IPOs or sales.

Prime determinants of growth

Advertisement
Stake.com

The private equity market is expected to witness notable growth owing to the potential for higher returns, access to specialized expertise and networks, and flexibility in investment strategies. Moreover, the opportunity for ESG integration is expected to provide a lucrative opportunity for the growth of the market during the forecast period. On the contrary, regulatory and compliance challenges and limited liquidity and exit options limit the growth of the private equity market.

Report Coverage & Details:

Report Coverage

Details

Forecast Period

Advertisement
Stake.com

2023–2032

Base Year

2022

Market Size in 2022

$445.4 billion

Advertisement
Stake.com

Market Size in 2032

$1,098.74 billion

CAGR

9.7 %

No. of Pages in Report

Advertisement
Stake.com

351

Segments Covered

Fund type, sector, and region.

Drivers

Potential for higher returns

Advertisement
Stake.com

Access to specialized expertise and networks Flexibility in investment strategies

Opportunity

Opportunity in ESG integration

Restraints

Regulatory and compliance challenges

Advertisement
Stake.com

Limited liquidity and exit options

COVID-19 Scenario

  • COVID-19 had a mixed impact on the private equity market. Initially, there was a downturn as uncertainty and market volatility surged, leading to deal postponements and valuation challenges.
  • However, as the economy stabilized and rebounded, the market saw increased opportunities for distressed asset acquisitions at attractive valuations. Sectors like technology, healthcare, and e-commerce experienced growth, bolstering the performance of certain private equity portfolios.
  • Overall, while the pandemic initially posed challenges, it also created avenues for strategic investments and lucrative opportunities, resulting in a mixed impact on the private equity landscape.

Request Customization: https://www.alliedmarketresearch.com/request-for-customization/7314

The buyout segment to maintain its leadership status throughout the forecast period

Based on fund type, the buyout segment held the highest market share in 2022, accounting for nearly one-third of the global private equity market revenue and is estimated to maintain its leadership status throughout the forecast period. This is due to its versatility and applicability across diverse industries. Buyout funds often acquire controlling stakes in established companies, enabling private equity firms to implement strategic changes, drive operational efficiencies, and ultimately generate substantial returns upon exit.  However, the infrastructure segment is projected to manifest the highest CAGR of 13.3% from 2023 to 2032. This is due to the global shifts toward sustainable development, increased demand for modern infrastructure, and the focus on renewable energy solutions. Infrastructure investments address critical needs for energy transition, transportation upgrades, and technological advancements, attracting private equity due to long-term revenue potential and the essential nature of these projects.

The technology segment to maintain its leadership status throughout the forecast period

Advertisement
Stake.com

On the basis of sector, the technology segment held the highest market share in 2022, accounting for more than one-fourth of the global private equity market revenue. This is due to its inherent dynamism and potential for disruptive innovation.  The attraction of private equity to technology lies in the rapid evolution of the sector, offering opportunities for high-growth investments in areas such as software, AI, and digital platforms. However, the industrial segment is projected to manifest the highest CAGR of 15.1% from 2022 to 2032. This is primarily due to the renewed focus on manufacturing advancements, automation, and Industry 4.0 initiatives. The interest in private equity in the industrial sector has surged due to opportunities to modernize manufacturing processes, embrace technological advancements, and pursue efficiency gains.

North America to maintain its dominance by 2032

On the basis of region, North America held the highest market share for more than one-third of the global private equity market in terms of revenue in 2022. This is due to the fact that the region has a well-established ecosystem for private equity, boasting a mature financial infrastructure, access to a vast pool of capital from institutional investors, and a robust regulatory environment conducive to investment activities. However, Asia-Pacific is expected to witness the fastest CAGR of 12.9% from 2023 to 2032. This is due to the fact that this region boasts rapid economic development, a burgeoning middle class, and an increase in entrepreneurial activity. In addition, there is a growth in openness to private equity investments, favorable demographics, and a rise in number of high-growth potential companies.

Leading Market Players: –

  • Apollo Global Management, Inc.
  • Bain Capital, LP.
  • Blackstone Inc.
  • EQT AB
  • HELLMAN & FRIEDMAN LLC
  • Insight Partners
  • KOHLBERG KRAVIS ROBERTS & CO. L.P.
  • Tarrant Capital IP, LLC
  • The Carlyle Group
  • Thoma Bravo

The report provides a detailed analysis of these key players in the global private equity market. These players have adopted different strategies such as product launch and agreement to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Key Benefits for Stakeholders

Advertisement
Stake.com
  • This report provides a quantitative analysis of the private equity market segments, current trends, estimations, and dynamics of the private equity market forecast from 2023 to 2032 to identify the prevailing private equity market opportunity.
  • Private equity market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the private equity market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global private equity market.
  • Private equity market player positioning facilitates benchmarking and provides a clear understanding of the present position of the private equity market players.
  • The report includes an analysis of the regional as well as global private equity market trends, key players, market segments, application areas, and market growth strategies.

Inquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/7314

Private Equity Market Report Highlights

By Fund Type

  • Buyout
  • Venture Capital
  • Real Estate
  • Infrastructure
  • Others

By Sector

  • Technology
  • Financial Services
  • Real Estate and Services
  • Healthcare
  • Energy and Power
  • Industrial
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Latin America, Middle East, Africa)

Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):

Cross-border Payments Market by Channel (Bank Transfer, Money Transfer Operator, Card Payment, Others), by Transaction Type (Business to Business (B2B), Customer to Business (C2B), Business to Customer (B2C), Customer to Customer (C2C)), by Enterprise Size (Large Enterprise Size, Small and Medium-sized Enterprises), by End User (Individuals, Businesses): Global Opportunity Analysis and Industry Forecast, 2023-2032

Autonomous Finance Market by Solution (Asset Management, Auto Payments, Digital Identity Management System, Liquidity Management, Loan Application Processing, Others), by End User (Banks, Financial Institutions, Insurance Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Cyber Insurance Market by Coverage (Data Breach, Cyber Liability, First-party Coverage, Third-party Coverage, Others), by Enterprise Size (Large Enterprise, Small and Medium-sized Enterprise), by Industry Vertical (BFSI, IT and Telecommunication, Retail and E-commerce, Healthcare, Manufacturing, Government and Public Sector, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Advertisement
Stake.com

Decentralized Finance Market by Component (Blockchain Technology, Decentralized Applications (dApps), Smart Contracts), by Application (Decentralized Exchanges, Compliance and Identity, Marketplaces and Liquidity, Payments, Data and Analytics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

E-commerce Market By Model Type (Business-to-consumer (B2C), Business-to-business (B2B)), By Offering (Beauty and Personal Care Products, Consumer Electronics, Fashion and Apparel, Household Products, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Exchange Traded Fund Market by Type (Fixed Income/Bonds ETFs, Equity ETFs, Commodity ETFs, Currency ETFs, Specialty ETFs, Others), by Distribution Channel (Retail, Institutional), by Investor Type (Individual Investor, Institutional Investor): Global Opportunity Analysis and Industry Forecast, 2022-2031

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Advertisement
Stake.com

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
[email protected]
Allied Market Research Blog: https://blog.alliedmarketresearch.com
BFSI Blog

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/private-equity-market-to-reach-1-098-74-billion-globally-by-2032-at-9-7-cagr-allied-market-research-302011163.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading

Trending